CIK 0000010795 · Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 220760120
- Phone
- 2018476800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-26 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Grant or award | +3,048 | 15,503 | ||
| 2025-11-26 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Shares withheld for taxes | −1,769 | 13,734 | ||
| 2025-11-26 | Feld Michael EVP, CRO & Pres. Life Sciences | Grant or award | +8,829 | 17,074 | ||
| 2025-11-26 | Feld Michael EVP, CRO & Pres. Life Sciences | Shares withheld for taxes | −419 | 16,655 | ||
| 2025-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Grant or award | +6,006 | 27,227 | ||
| 2025-11-26 | DelOrefice Christopher EVP & Chief Financial Officer | Shares withheld for taxes | −4,245 | 22,982 | ||
| 2025-11-26 | Byrd Richard EVP & President Interventional | Grant or award | +6,447 | 13,183 | ||
| 2025-11-26 | Byrd Richard EVP & President Interventional | Grant or award | +2,385 | 15,568 | ||
| 2025-11-26 | Byrd Richard EVP & President Interventional | Shares withheld for taxes | −1,719 | 13,849 | ||
| 2025-11-26 | Muhsin Bilal EVP & President Connected Care | Grant or award | +9,530 | 21,751 | ||
| 2025-11-26 | Polen Thomas E Jr Chairman, CEO and President | Grant or award | +22,521 | 122,892 | ||
| 2025-11-26 | Polen Thomas E Jr Chairman, CEO and President | Shares withheld for taxes | −17,421 | 105,471 | ||
| 2025-11-26 | Polen Thomas E Jr Chairman, CEO and President | Grant or award · Stock Appreciation Rights | +165,581 | 165,581 | ||
| 2025-11-26 | Spikner Pamela L. SVPController & Chief Acct Off | Grant or award | +1,234 | 1,916 | ||
| 2025-11-07 | SCOTT BERTRAM L Director | Sale | −217 | $176.58 | $38K | 35,816 |
| 2025-11-04 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +34 | $178.71 | $6K | 1,675 |
| 2025-11-04 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under BD Deferred Compensation Plan | +168 | $178.71 | $30K | 11,316 |
| 2025-10-27 | Feld Michael EVP & President, Life Sciences | Sale 10b5-1 | −57 | $186.01 | $11K | 8,245 |
| 2025-09-26 | Feld Michael EVP & President, Life Sciences | Sale 10b5-1 | −58 | $181.03 | $10K | 8,302 |
| 2025-09-10 | Fraser Claire Director | Sale | −917 | $187.50 | $172K | 22,226 |
Page 5 of 7 · 135 trades